In SARS-CoV-2 infected individuals increased levels and oxidation of SPTA1 peptides are noted reflecting structural aberration of RBCs [104], which may potentially contribute to the severity of hypoxemia, thromboembolism, and coagulation defects noted in the manifestation of COVID-19. This evidence concerns the gene SPTA1 and COVID-19.